GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that it had made equity grants to new employees under its 2019 Inducement Plan (the “Plan”) in accordance with NYSE American Company Guide Section 711(a). On April 2, 2020, Senseonics Compensation Committee granted five new non-exe
Full ArticleSenseonics Announces Equity Grants To Employees Under Inducement Plan
Business Wire
0 shares
1 views